Fork me on GitHub

Biopharma innovation: A marketplace for discontinued drug programs

Resized image of Ritalin-SR-20mg-full.png; squ...Image via Wikipedia

So I am supposed to be writing about innovation in the Biopharma industry. Here’s in idea that I’ve had that might be worth discussing (sometimes I wish I had the patience to write with the depth of Michael Nielsen). Last year we heard about Goldman Sachs funding an innovative pharma business model, but at that time I felt that the stage they had chosen was too late. One of the biggest expenses in pharmaceutical drug development is attrition. For all kinds of reasons, various programs never make it, leads are discarded, etc. I wonder if there is a place for marketplace or pool where companies can throw in discarded compounds or programs. Then, someone else can pick up a compound, or lead series or two, associated information which could be made available (negative results, etc) and then run with it, with some kind of standard licensing/revenue sharing terms in place. A different set of minds, a different platform, and you never know what you might get at the end. Has anyone tried anything like this?

Reblog this post [with Zemanta]

This entry was posted in Biopharma innovation, Drug Development, Innovation, Pharma. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

blog comments powered by Disqus
  • Archives

  • Disclaimer

    All opinions on this blog are my own and do not reflect those of my employers, past or present